Pharvaris
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharvaris and other ETFs, options, and stocks.About PHVS
Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases.
CEOBerndt A. E. Modig
CEOBerndt A. E. Modig
Employees108
Employees108
HeadquartersLeiden, Zuid-Holland
HeadquartersLeiden, Zuid-Holland
Founded2015
Founded2015
Employees108
Employees108
PHVS Key Statistics
Market cap1.51B
Market cap1.51B
Price-Earnings ratio-7.32
Price-Earnings ratio-7.32
Dividend yield—
Dividend yield—
Average volume227.63K
Average volume227.63K
High today$25.05
High today$25.05
Low today$23.48
Low today$23.48
Open price$24.36
Open price$24.36
Volume360.55K
Volume360.55K
52 Week high$26.33
52 Week high$26.33
52 Week low$11.51
52 Week low$11.51
Stock Snapshot
As of today, Pharvaris(PHVS) shares are valued at $23.55. The company's market cap stands at 1.51B, with a P/E ratio of -7.32.
During the trading session on 2025-11-15, Pharvaris(PHVS) shares reached a daily high of $25.05 and a low of $23.48. At a current price of $23.55, the stock is +0.3% higher than the low and still -6.0% under the high.
Trading volume for Pharvaris(PHVS) stock has reached 360.55K, versus its average volume of 227.63K.
The stock's 52-week range extends from a low of $11.51 to a high of $26.33.
The stock's 52-week range extends from a low of $11.51 to a high of $26.33.
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%
People also own
Based on the portfolios of people who own PHVS. This list is generated using Robinhood data, and it’s not a recommendation.